Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trialLancet 2021 Nov 16;[EPub Ahead of Print], DCW Lau, L Erichsen, AM Francisco, A Satylganova, CW le Roux, B McGowan, SD Pedersen, KH Pietiläinen, D Rubino, RL Batterham
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.